3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
2
Interventions
enzalutamide
16
Magnetic Resonance Spectroscopy
16
apalutamide
15
Prednisone
12
Androgen Antagonists
12
Abiraterone Acetate
12
Specimen Handling
11
darolutamide
7
abiraterone
7
Radiotherapy
7
Pluvicto
6
Nivolumab
6
Docetaxel
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
cabazitaxel
5
Radiosurgery
5
Lutetium-177
5
Biopsy
5
radium Ra 223 dichloride
4
cabozantinib
4
bicalutamide
4
atezolizumab
4
Standard of Care
4
Lutetium
4
olaparib
3
gallium 68 PSMA-11
3
Watchful Waiting
3
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Fulvestrant
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Electroporation
×
30 days
×
Clear all
NCT07623941
2026-06-03
CUIMC Focal Therapy Registry
Columbia University
Recruiting
1,000 enrolled
NCT04972097
2026-06-02
PRESERVE
Angiodynamics, Inc.
Phase NA
Completed
121 enrolled
19 charts